RNA Clinical Trials Resources

81. Acute Myeloid Leukemia: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Gain a better understanding of the incidence, distribution, and possible control of acute myeloid leukemia (AML) in the Asia Pacific region, the standard of care, the trial landscape, and more.

82. Prostate Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of prostate cancer (PCa) in the Asia Pacific region, the standard of care, the trial landscape, and more.

83. Breast Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of breast cancer in the Asia Pacific region, the standard of care, the trial landscape, and more.

84. Melanoma: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of melanoma in the Asia Pacific region, the standard of care, the trial landscape, and more.

85. Ovarian Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/8/2023

    Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.

86. Expert Consulting, MRCT Strategy Rescues Oncology Program 5/8/2023

    Uncover how teams identified missing IB data and necessary additional details needed to outline U.S. study challenges as required for local authority approval in a previously failing study.

87. Modulate mRNA Therapy Effectiveness Using Modified Ribonucleotides 3/20/2023

    Learn about the problem of immunogenicity of mRNA, modified mRNA via in vitro transcription production, and choosing fit-for-purpose modified ribonucleotides.

88. Understanding CRISPR Clinical Trials: Your Questions Answered 3/15/2023

    CRISPR technology is revolutionizing cell and gene therapies, but how do CRISPR clinical trials work? Follow this explanation of CRISPR therapies from the discovery phase to FDA approval.

89. Key Challenges for CRISPR In Clinical Development 2/28/2023

    Learn how to approach CRISPR cell and gene therapy development challenges, such as regulatory hurdles, ensuring consistency, finding qualified and experienced staff, and obtaining GMP-Grade reagents.

90. Leveraging Global Drug Development Programs To Ensure Trial Success 2/7/2023

    Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.